MetLife Investment Management’s Intellia Therapeutics NTLA Stock Holding History

MetLife Investment Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$757K	Buy	59,080 +2,474	+4%	+$31.5K	﹤0.01%	1545
2025 Q4	$509K	Sell	56,606 -4,360	-7%	-$60K	﹤0.01%	1784
2025 Q3	$1.05M	Hold	60,966	–	–	0.01%	1417
2025 Q2	$572K	Buy	60,966 +2,420	+4%	+$19.9K	﹤0.01%	1612
2025 Q1	$416K	Sell	58,546 -641	-1%	-$6.47K	﹤0.01%	1813
2024 Q4	$690K	Buy	59,187 +3,491	+6%	+$54.5K	﹤0.01%	1616
2024 Q3	$1.14M	Hold	55,696	–	–	0.01%	1318
2024 Q2	$1.25M	Buy	55,696 +9,200	+20%	+$219K	0.01%	1234
2024 Q1	$1.28M	Hold	46,496	–	–	0.01%	1160
2023 Q4	$1.42M	Hold	46,496	–	–	0.01%	1124
2023 Q3	$1.47M	Hold	46,496	–	–	0.01%	1039
2023 Q2	$1.9M	Buy	46,496 +2,465	+6%	+$100K	0.01%	951
2023 Q1	$1.64M	Hold	44,031	–	–	0.01%	983
2022 Q4	$1.54M	Buy	44,031 +3,930	+10%	+$187K	0.01%	1008
2022 Q3	$2.24M	Buy	40,101 +917	+2%	+$56.9K	0.02%	829
2022 Q2	$2.03M	Buy	39,184 +1,822	+5%	+$92.5K	0.02%	900
2022 Q1	$2.72M	Buy	37,362 +13,209	+55%	+$1.12M	0.02%	861
2021 Q4	$2.86M	Hold	24,153	–	–	0.02%	696
2021 Q3	$3.24M	Buy	24,153 +1,369	+6%	+$207K	0.03%	595
2021 Q2	$3.69M	Buy	22,784 +2,841	+14%	+$221K	0.03%	554
2021 Q1	$1.6M	Hold	19,943	–	–	0.01%	948
2020 Q4	$1.08M	Hold	19,943	–	–	0.01%	1094
2020 Q3	$396K	Hold	19,943	–	–	﹤0.01%	1493
2020 Q2	$419K	Buy	19,943 +4,202	+27%	+$71.4K	﹤0.01%	1481
2020 Q1	$193K	Hold	15,741	–	–	﹤0.01%	1718
2019 Q4	$231K	Hold	15,741	–	–	﹤0.01%	1903
2019 Q3	$210K	Hold	15,741	–	–	﹤0.01%	1917
2019 Q2	$258K	Hold	15,741	–	–	﹤0.01%	1883
2019 Q1	$269K	Hold	15,741	–	–	﹤0.01%	1816
2018 Q4	$215K	Hold	15,741	–	–	﹤0.01%	1870
2018 Q3	$451K	Hold	15,741	–	–	﹤0.01%	1601
2018 Q2	$431K	Buy	15,741 +8,144	+107%	+$197K	0.01%	1494
2018 Q1	$160K	Hold	7,597	–	–	﹤0.01%	2005
2017 Q4	$146K	Buy	+7,597	New	+$175K	﹤0.01%	2081